These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12373863)

  • 21. Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease.
    Martiskainen H; Haapasalo A; Kurkinen KM; Pihlajamäki J; Soininen H; Hiltunen M
    Expert Opin Ther Targets; 2013 Jul; 17(7):781-94. PubMed ID: 23573918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition?
    Patil SP; Ballard R; Sanchez S; Osborn J; Santangelo D
    Med Hypotheses; 2012 Apr; 78(4):494-6. PubMed ID: 22285195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's disease and cholesterol: the fat connection.
    Canevari L; Clark JB
    Neurochem Res; 2007; 32(4-5):739-50. PubMed ID: 17191138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic Analysis of Mitochondria-Enriched Fraction Isolated from the Frontal Cortex and Hippocampus of Apolipoprotein E Knockout Mice Treated with Alda-1, an Activator of Mitochondrial Aldehyde Dehydrogenase (ALDH2).
    Stachowicz A; Olszanecki R; Suski M; Głombik K; Basta-Kaim A; Adamek D; Korbut R
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein.
    Cole GM; Ard MD
    Microsc Res Tech; 2000 Aug; 50(4):316-24. PubMed ID: 10936886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ApoE: crossroads between Alzheimer's disease and atherosclerosis.
    Stojakovic T; Scharnagl H; März W
    Semin Vasc Med; 2004 Aug; 4(3):279-85. PubMed ID: 15630629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.
    Fagan AM; Younkin LH; Morris JC; Fryer JD; Cole TG; Younkin SG; Holtzman DM
    Ann Neurol; 2000 Aug; 48(2):201-10. PubMed ID: 10939571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Perspectives on the amyloid cascade hypothesis of Alzheimer's disease].
    Simón AM; Frechilla D; del Río J
    Rev Neurol; 2010 Jun; 50(11):667-75. PubMed ID: 20514639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF lipoproteins and Alzheimer's disease.
    Neely MD; Montine TJ
    J Nutr Health Aging; 2002; 6(6):383-91. PubMed ID: 12459889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Physiology and pathology of the lipid transport in the brain].
    Chiba H
    Rinsho Byori; 1996 Mar; 44(3):231-6. PubMed ID: 8857165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
    Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
    Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Niemann-Pick type C disease: accelerated neurofibrillary tangle formation and amyloid beta deposition associated with apolipoprotein E epsilon 4 homozygosity.
    Saito Y; Suzuki K; Nanba E; Yamamoto T; Ohno K; Murayama S
    Ann Neurol; 2002 Sep; 52(3):351-5. PubMed ID: 12205649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease.
    Salameh TS; Rhea EM; Banks WA; Hanson AJ
    Exp Biol Med (Maywood); 2016 Sep; 241(15):1676-83. PubMed ID: 27470930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New gene tied to common form of Alzheimer's.
    Marx J
    Science; 1998 Jul; 281(5376):507, 509. PubMed ID: 9705719
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic mutations of APOEε4 carriers in cardiovascular patients lead to the development of insulin resistance and risk of Alzheimer's disease.
    Jabeen K; Rehman K; Akash MSH
    J Biochem Mol Toxicol; 2022 Feb; 36(2):e22953. PubMed ID: 34757642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoproteins in the Central Nervous System: From Biology to Pathobiology.
    Raulin AC; Martens YA; Bu G
    Annu Rev Biochem; 2022 Jun; 91():731-759. PubMed ID: 35303786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid metabolism and glial lipoproteins in the central nervous system.
    Hayashi H
    Biol Pharm Bull; 2011; 34(4):453-61. PubMed ID: 21467629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasticity and the spread of Alzheimer's disease-like changes.
    Ohm TG; Glöckner F; Distl R; Treiber-Held S; Meske V; Schönheit B
    Neurochem Res; 2003 Nov; 28(11):1715-23. PubMed ID: 14584825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's amyloid beta and lipid metabolism: a missing link?
    Koudinov AR; Berezov TT; Koudinova NV
    FASEB J; 1998 Sep; 12(12):1097-9. PubMed ID: 9737712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.